This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holzenberger, M. Articles by Le Bouc, Y. Search for Related Content PubMed PubMed Citation Articles by Holzenberger, M. Articles by Le Bouc, Y.

A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit¹

U-515 INSERM, Hôpital Saint-Antoine (M.H., P.L., B.D., L.P., M.B., Y.L.B.), 75571 Paris; and U-380, INSERM, Faculté de Médecine Cochin-Port Royal (G.H.), 75014 Paris, France

Address all correspondence and requests for reprints to: Dr. Martin Holzenberger, U-515, INSERM, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France. E-mail: holzenberger{at}st-antoine.inserm.fr

The insulin-like growth factor (IGF) system is a major regulator of somatic growth in vertebrates. Both ligands (IGF-I and IGF-II) signal via the same IGF receptor (IGF-IR). Classical IGF-IR invalidation is lethal at birth, so that conditional models are needed to study the postnatal role of this receptor. To establish a genetically inducible invalidation of IGF-IR, we targeted the IGF-IR gene using a construct that introduced a neomycin resistance cassette into intron 2, leaving the rest of the gene intact. This neomycin resistance cassette interfered with the processing of the primary transcript, resulting in there being 12% fewer IGF-binding sites at the cell surface in heterozygous mice and 41% fewer in homozygous mice. Hetero- and homozygous offspring grew more slowly than their wild-type littermates. This difference was noticeable from 4 weeks after birth and was significant from 5 weeks after birth in males. In females, the effect on postnatal growth of insertion of the neo cassette was not significant. In males, IGF-I levels increased moderately (+26%) but significantly, indicating effective feedback regulation of the IGF system. IGF-binding protein-4 (IGFBP-4) levels, estimated by Western ligand blotting, were low in homozygotes (-38%), whereas IGFBP-1, -2, and -3 levels were unaffected. In females, IGF-I and IGFBP-1, -2, -3, and -4 levels did not differ significantly among heterozygous, homozygous, and wild-type animals. We investigated the molecular mechanism involved and characterized two RNA-splicing events that could account for the decrease in IGF-IR. The phenotype of these mice developed exclusively postnatally, and body proportions were maintained. IGF-IRneo mice constitute a new model for human postnatal growth deficiency.

This article has been cited by other articles:

				A. Cadoret, C. Rey, D. Wendum, K. Elriz, F. Tronche, M. Holzenberger, and C. Housset IGF-1R Contributes to Stress-Induced Hepatocellular Damage in Experimental Cholestasis Am. J. Pathol., August 1, 2009; 175(2): 627 - 635. [Abstract] [Full Text] [PDF]

				P. Fang, I. D. Schwartz, B. D. Johnson, M. A. Derr, C. T. Roberts Jr., V. Hwa, and R. G. Rosenfeld Familial Short Stature Caused by Haploinsufficiency of the Insulin-Like Growth Factor I Receptor due to Nonsense-Mediated Messenger Ribonucleic Acid Decay J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1740 - 1747. [Abstract] [Full Text] [PDF]

				L. Kappeler, C. De Magalhaes Filho, P. Leneuve, J. Xu, N. Brunel, C. Chatziantoniou, Y. Le Bouc, and M. Holzenberger Early Postnatal Nutrition Determines Somatotropic Function in Mice Endocrinology, January 1, 2009; 150(1): 314 - 323. [Abstract] [Full Text] [PDF]

				N. Kloting, L. Koch, T. Wunderlich, M. Kern, K. Ruschke, W. Krone, J. C. Bruning, and M. Bluher Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth Diabetes, August 1, 2008; 57(8): 2074 - 2082. [Abstract] [Full Text] [PDF]

				P Froment, M Vigier, D Negre, I Fontaine, J Beghelli, F L Cosset, M Holzenberger, and P Durand Inactivation of the IGF-I receptor gene in primary Sertoli cells highlights the autocrine effects of IGF-I J. Endocrinol., September 1, 2007; 194(3): 557 - 568. [Abstract] [Full Text] [PDF]

				M J E Walenkamp and J M Wit Genetic disorders in the GH IGF-I axis in mouse and man Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S15 - S26. [Abstract] [Full Text] [PDF]

				J. Cheng and J. Du Mechanical Stretch Simulates Proliferation of Venous Smooth Muscle Cells Through Activation of the Insulin-Like Growth Factor-1 Receptor Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1744 - 1751. [Abstract] [Full Text] [PDF]

				P. G. Laustsen, S. J. Russell, L. Cui, A. Entingh-Pearsall, M. Holzenberger, R. Liao, and C. R. Kahn Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function Mol. Cell. Biol., March 1, 2007; 27(5): 1649 - 1664. [Abstract] [Full Text] [PDF]

				M. J. E. Walenkamp, H. J. van der Kamp, A. M. Pereira, S. G. Kant, H. A. van Duyvenvoorde, M. F. Kruithof, M. H. Breuning, J. A. Romijn, M. Karperien, and J. M. Wit A Variable Degree of Intrauterine and Postnatal Growth Retardation in a Family with a Missense Mutation in the Insulin-Like Growth Factor I Receptor J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3062 - 3070. [Abstract] [Full Text] [PDF]

				K. Raile, J. Klammt, A. Schneider, A. Keller, S. Laue, R. Smith, R. Pfaffle, J. Kratzsch, E. Keller, and W. Kiess Clinical and Functional Characteristics of the Human Arg59Ter Insulin-Like Growth Factor I Receptor (IGF1R) Mutation: Implications for a Gene Dosage Effect of the Human IGF1R J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2264 - 2271. [Abstract] [Full Text] [PDF]

				A. D. Gagliardi, E. Y. W. Kuo, S. Raulic, G. F. Wagner, and G. E. DiMattia Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E92 - E105. [Abstract] [Full Text] [PDF]

				A. Entingh-Pearsall and C. R. Kahn Differential Roles of the Insulin and Insulin-like Growth Factor-I (IGF-I) Receptors in Response to Insulin and IGF-I J. Biol. Chem., September 3, 2004; 279(36): 38016 - 38024. [Abstract] [Full Text] [PDF]

				Y. Okubo, K. Siddle, H. Firth, S. O'Rahilly, L. C. Wilson, L. Willatt, T. Fukushima, S.-I. Takahashi, C. J. Petry, T. Saukkonen, et al. Cell Proliferation Activities on Skin Fibroblasts from a Short Child with Absence of One Copy of the Type 1 Insulin-Like Growth Factor Receptor (IGF1R) Gene and a Tall Child with Three Copies of the IGF1R Gene J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5981 - 5988. [Abstract] [Full Text] [PDF]

				P. Leneuve, S. Colnot, G. Hamard, F. Francis, M. Niwa-Kawakita, M. Giovannini, and M. Holzenberger Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles Nucleic Acids Res., March 1, 2003; 31(5): e21 - e21. [Abstract] [Full Text] [PDF]

				Z.-J. Lan, A. C.-K. Chung, X. Xu, F. J. DeMayo, and A. J. Cooney The Embryonic Function of Germ Cell Nuclear Factor Is Dependent on the DNA Binding Domain J. Biol. Chem., December 20, 2002; 277(52): 50660 - 50667. [Abstract] [Full Text] [PDF]

				K. A. Steinbrecher, S. A. Wowk, J. A. Rudolph, D. P. Witte, and M. B. Cohen Targeted Inactivation of the Mouse Guanylin Gene Results in Altered Dynamics of Colonic Epithelial Proliferation Am. J. Pathol., December 1, 2002; 161(6): 2169 - 2178. [Abstract] [Full Text] [PDF]

				I. Lagutina, S. J. Conway, J. Sublett, and G. C. Grosveld Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors Mol. Cell. Biol., October 15, 2002; 22(20): 7204 - 7216. [Abstract] [Full Text] [PDF]

				P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]

				B. Ducos, S. Cabrol, M. Houang, L. Perin, M. Holzenberger, and Y. Le Bouc IGF Type 1 Receptor Ligand Binding Characteristics Are Altered in a Subgroup of Children with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5516 - 5524. [Abstract] [Full Text] [PDF]

				M. Holzenberger, G. Hamard, R. Zaoui, P. Leneuve, B. Ducos, C. Beccavin, L. Perin, and Y. Le Bouc Experimental IGF-I Receptor Deficiency Generates a Sexually Dimorphic Pattern of Organ-Specific Growth Deficits in Mice, Affecting Fat Tissue in Particular Endocrinology, October 1, 2001; 142(10): 4469 - 4478. [Abstract] [Full Text] [PDF]

				Z Laron Insulin-like growth factor 1 (IGF-1): a growth hormone Mol. Pathol., October 1, 2001; 54(5): 311 - 316. [Abstract] [Full Text] [PDF]

				A. A. Butler and D. LeRoith Minireview: Tissue-Specific Versus Generalized Gene Targeting of the igf1 and igf1r Genes and Their Roles in Insulin-Like Growth Factor Physiology Endocrinology, May 1, 2001; 142(5): 1685 - 1688. [Abstract] [Full Text]

				M. Holzenberger, C. Lenzner, P. Leneuve, R. Zaoui, G. Hamard, S. Vaulont, and Y. L. Bouc Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene Nucleic Acids Res., November 1, 2000; 28(21): e92 - e92. [Abstract] [Full Text] [PDF]